{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T10:59:02Z","timestamp":1781780342772,"version":"3.54.5"},"reference-count":43,"publisher":"BMJ","issue":"6","license":[{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"unspecified","delay-in-days":17,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Union","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"crossref"}]},{"name":"European Institute of Innovation and Technology (EIT) Health","award":["BP 2022-2024. Activity Grant n\u00ba230127"],"award-info":[{"award-number":["BP 2022-2024. Activity Grant n\u00ba230127"]}]},{"name":"EIT"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2026,6,1]]},"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Glial fibrillar acidic protein (GFAP) and ubiquitin carboxy-terminal hydrolase L1 (UCH-L1) have been shown to rule out CT-detectable intracranial lesions in patients with mild traumatic brain injury (mTBI) when assessed within the first 12 hours after injury. These biomarkers have been validated across different laboratory-based and point-of-care testing platforms. The combined biomarker test has been incorporated into several mTBI management algorithms in Europe. However, data regarding its real-world application, including patients with neurological comorbidities and its impact on reducing CT utilisation or emergency department (ED) length of stay, are lacking. This study will evaluate the performance of an automated laboratory-based assay for serum GFAP and UCH-L1 when integrated into a standardised clinical pathway for the diagnostic management of patients with mTBI. In addition, the study will assess its potential value in reducing CT scan prescription and ED time.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>This single-centre observational study, with prospective data collection before and after the implementation of a combined test measuring GFAP and UCH-L1 in the clinical laboratory, will be conducted at Hospital Universitario 12 de Octubre, Madrid, Spain. Patients with clinically defined mTBI will be managed according to a newly implemented clinical pathway including biomarker testing. mTBI will be defined using predefined clinical criteria including a plausible traumatic mechanism, Glasgow Coma Scale score 13\u201315 assessed 30\u2009min or more after injury, and compatible signs and\/or symptoms of brain injury. Eligible patients must undergo blood sampling within 12 hours of injury and before imaging prescription. The effectiveness of this management approach will be compared with a previously established cohort of patients, prospectively enrolled under identical inclusion and exclusion criteria. A cohort of 1000 patients with mTBI, in whom biomarker testing was used in their management, will be included in the post implementation group. The pre-implementation cohort will be drawn from a comparable time period. The primary outcome measures are: the diagnostic performance of GFAP and UCH-L1, measured using an automated assay, for discriminating between patients with positive and negative findings on brain CT scans; the safety of the new clinical pathway in terms of complications such as unexpected surgery or deterioration, as well as the reduction in CT use after the implementation. Secondary objectives will be reduction in ED times and direct costs, as well as physicians\u2019 compliance with the algorithms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>The study was reviewed by the Institutional Research Committee of Hospital 12 de Octubre, Madrid, Spain (Ref TP25\/0144) and deemed exempt from formal ethical approval and informed consent requirements. This study\u2019s results will be presented at national and international meetings, including meetings of patient associations, and published in peer-reviewed journals.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" specific-use=\"clinicaltrial results\" xlink:href=\"NCT07311486\">NCT07311486<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2026-120021","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T10:50:41Z","timestamp":1781779841000},"page":"e120021","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Study protocol for investigating real-world implementation of a combined glial fibrillary acidic protein (GFAP) and ubiquitin carboxy-terminal hydrolase L1 (UCH-L1) blood test in the management of adult mild traumatic brain injury in a single-centre European emergency department: the IMPACTS-BRAINI study"],"prefix":"10.1136","volume":"16","clinical-trial-number":[{"clinical-trial-number":"nct07311486","registry":"10.18810\/clinical-trials-gov","type":"results"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3996-0554","authenticated-orcid":false,"given":"Alfonso","family":"Lagares","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Hospital Universitario 12 de Octubre, Madrid, Community of Madrid, Spain"},{"name":"Instituto de Investigaci\u00f3n Sanitaria imas12, Hospital Universitario 12 de Octubre, Madrid, Spain"},{"name":"Department of Surgery, Facultad de Medicina, Universidad Complutense de Madrid, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Maldonado","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Hospital Universitario 12 de Octubre, Madrid, Community of Madrid, Spain"},{"name":"Instituto de Investigaci\u00f3n Sanitaria imas12, Hospital Universitario 12 de Octubre, Madrid, Spain"},{"name":"Department of Surgery, Facultad de Medicina, Universidad Complutense de Madrid, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreea","family":"Baciu","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Hospital Universitario 12 de Octubre, Madrid, Community of Madrid, Spain"},{"name":"Instituto de Investigaci\u00f3n Sanitaria imas12, Hospital Universitario 12 de Octubre, Madrid, Spain"},{"name":"Department of Surgery, Facultad de Medicina, Universidad Complutense de Madrid, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leandro","family":"Tosi","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Hospital Universitario 12 de Octubre, Madrid, Community of Madrid, Spain"},{"name":"Instituto de Investigaci\u00f3n Sanitaria imas12, Hospital Universitario 12 de Octubre, Madrid, Spain"},{"name":"Department of Surgery, Facultad de Medicina, Universidad Complutense de Madrid, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Loynaz","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Hospital Universitario 12 de Octubre, Madrid, Community of Madrid, Spain"},{"name":"Instituto de Investigaci\u00f3n Sanitaria imas12, Hospital Universitario 12 de Octubre, Madrid, Spain"},{"name":"Department of Surgery, Facultad de Medicina, Universidad Complutense de Madrid, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Martinez","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Hospital Universitario 12 de Octubre, Madrid, Community of Madrid, Spain"},{"name":"Instituto de Investigaci\u00f3n Sanitaria imas12, Hospital Universitario 12 de Octubre, Madrid, Spain"},{"name":"Department of Surgery, Facultad de Medicina, Universidad Complutense de Madrid, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Mar\u00eda","family":"Casta\u00f1o Le\u00f3n","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Hospital Universitario 12 de Octubre, Madrid, Community of Madrid, Spain"},{"name":"Instituto de Investigaci\u00f3n Sanitaria imas12, Hospital Universitario 12 de Octubre, Madrid, Spain"},{"name":"Department of Surgery, Facultad de Medicina, Universidad Complutense de Madrid, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Hern\u00e1ndez-S\u00e1nchez","sequence":"additional","affiliation":[{"name":"Instituto de Investigaci\u00f3n Sanitaria imas12, Hospital Universitario 12 de Octubre, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noelia","family":"Garc\u00eda Barrio","sequence":"additional","affiliation":[{"name":"Digital Health Group, Instituto de investigaci\u00f3n Sanitaria imas12, Hospital Universitario 12 de Octubre, Madrid, Comunidad de Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"de la Cruz","sequence":"additional","affiliation":[{"name":"Instituto de Investigaci\u00f3n Sanitaria imas12, Hospital Universitario 12 de Octubre, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"S\u00e1nchez","sequence":"additional","affiliation":[{"name":"Instituto de Investigaci\u00f3n Sanitaria imas12, Hospital Universitario 12 de Octubre, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Lopez Jim\u00e9nez","sequence":"additional","affiliation":[{"name":"Servicio de An\u00e1lisis Cl\u00ednicos-Bioqu\u00edmica Cl\u00ednica, Hospital Universitario 12 de Octubre, Madrid, Community of Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Cueto-Felgueroso","sequence":"additional","affiliation":[{"name":"Servicio de An\u00e1lisis Cl\u00ednicos-Bioqu\u00edmica Cl\u00ednica, Hospital Universitario 12 de Octubre, Madrid, Community of Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Carrasco","sequence":"additional","affiliation":[{"name":"Servicio de An\u00e1lisis Cl\u00ednicos-Bioqu\u00edmica Cl\u00ednica, Hospital Universitario 12 de Octubre, Madrid, Community of Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Marquez","sequence":"additional","affiliation":[{"name":"Servicio de An\u00e1lisis Cl\u00ednicos-Bioqu\u00edmica Cl\u00ednica, Hospital Universitario 12 de Octubre, Madrid, Community of Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alba","family":"Mar\u00eda Fern\u00e1ndez del Pozo","sequence":"additional","affiliation":[{"name":"Servicio de An\u00e1lisis Cl\u00ednicos-Bioqu\u00edmica Cl\u00ednica, Hospital Universitario 12 de Octubre, Madrid, Community of Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Amil","sequence":"additional","affiliation":[{"name":"Servicio de An\u00e1lisis Cl\u00ednicos-Bioqu\u00edmica Cl\u00ednica, Hospital Universitario 12 de Octubre, Madrid, Community of Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Arias","sequence":"additional","affiliation":[{"name":"Servicio de An\u00e1lisis Cl\u00ednicos-Bioqu\u00edmica Cl\u00ednica, Hospital Universitario 12 de Octubre, Madrid, Community of Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Odile","family":"Mejan","sequence":"additional","affiliation":[{"name":"R&D Immunoassays, Chemin de l'Orme, bioM\u00e9rieux, Marcy l'Etoile, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,6,18]]},"reference":[{"key":"2026061803502147000_16.6.e120021.1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(17)30371-X"},{"key":"2026061803502147000_16.6.e120021.2","doi-asserted-by":"publisher","DOI":"10.1089\/neu.2016.4919"},{"key":"2026061803502147000_16.6.e120021.3","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1007\/s00068-022-01902-5","article-title":"Variability in the indication of brain CT scan after mild traumatic brain injury. A transnational survey","volume":"49","author":"Lagares","year":"2023","journal-title":"Eur J Trauma Emerg Surg"},{"key":"2026061803502147000_16.6.e120021.4","unstructured":"Gomez PA , Lobato RD , Lagares A , et al . Mild head injury in adults. A review. Neurocirugia 2000;11."},{"key":"2026061803502147000_16.6.e120021.5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200007133430204"},{"key":"2026061803502147000_16.6.e120021.6","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)04561-X"},{"key":"2026061803502147000_16.6.e120021.7","article-title":"Management of patients suffering from mild traumatic brain injury 2023","volume":"42","author":"Gil-Jardin\u00e9","year":"2023","journal-title":"Anaesth Crit Care Pain Med"},{"key":"2026061803502147000_16.6.e120021.8","first-page":"483","article-title":"CT overuse for mild traumatic brain injury","volume":"38","author":"Melnick","year":"2012","journal-title":"Jt Comm J Qual Patient Saf"},{"key":"2026061803502147000_16.6.e120021.9","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s10140-024-02247-9","article-title":"Overutilization of head computed tomography in cases of mild traumatic brain injury: a systematic review and meta-analysis","volume":"31","author":"Rezaee","year":"2024","journal-title":"Emerg Radiol"},{"key":"2026061803502147000_16.6.e120021.10","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1080\/026990501458353","article-title":"Management of mild traumatic brain injury: lack of consensus in Europe","volume":"15","author":"De Kruijk","year":"2001","journal-title":"Brain Inj"},{"key":"2026061803502147000_16.6.e120021.11","doi-asserted-by":"publisher","DOI":"10.1089\/neu.2017.5182"},{"key":"2026061803502147000_16.6.e120021.12","doi-asserted-by":"crossref","DOI":"10.3390\/jpm15080350","article-title":"Blood Biomarkers as Optimization Tools for Computed Tomography in Mild Traumatic Brain Injury Management in Emergency Departments: A Systematic Review","volume":"15","author":"Caballero Ballesteros","year":"2025","journal-title":"J Pers Med"},{"key":"2026061803502147000_16.6.e120021.13","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.1089\/neu.2018.6351","article-title":"Prospective Validation of the Scandinavian Guidelines for Initial Management of Minimal, Mild, and Moderate Head Injuries in Adults","volume":"36","author":"Minkkinen","year":"2019","journal-title":"J Neurotrauma"},{"key":"2026061803502147000_16.6.e120021.14","doi-asserted-by":"crossref","DOI":"10.1186\/1741-7015-11-50","article-title":"Scandinavian guidelines for initial management of minimal, mild and moderate head injuries in adults: an evidence and consensus-based update","volume":"11","author":"Und\u00e9n","year":"2013","journal-title":"BMC Med"},{"key":"2026061803502147000_16.6.e120021.15","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105477","article-title":"An automated blood test for glial fibrillary acidic protein (GFAP) and ubiquitin carboxy-terminal hydrolase L1 (UCH-L1) to predict the absence of intracranial lesions on head CT in adult patients with mild traumatic brain injury: BRAINI, a multicentre observational study in Europe","volume":"110","author":"Lagares","year":"2024","journal-title":"EBioMedicine"},{"key":"2026061803502147000_16.6.e120021.16","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(18)30231-X"},{"key":"2026061803502147000_16.6.e120021.17","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1001\/jamaneurol.2016.0039","article-title":"Time Course and Diagnostic Accuracy of Glial and Neuronal Blood Biomarkers GFAP and UCH-L1 in a Large Cohort of Trauma Patients With and Without Mild Traumatic Brain Injury","volume":"73","author":"Papa","year":"2016","journal-title":"JAMA Neurol"},{"key":"2026061803502147000_16.6.e120021.18","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.1302","article-title":"Evaluation of Glial and Neuronal Blood Biomarkers Compared With Clinical Decision Rules in Assessing the Need for Computed Tomography in Patients With Mild Traumatic Brain Injury","volume":"5","author":"Papa","year":"2022","journal-title":"JAMA Netw Open"},{"key":"2026061803502147000_16.6.e120021.19","doi-asserted-by":"publisher","DOI":"10.1089\/neu.2020.7140"},{"key":"2026061803502147000_16.6.e120021.20","doi-asserted-by":"crossref","first-page":"e1630","DOI":"10.1089\/neu.2023.0491","article-title":"Evaluation of Glial Fibrillary Acidic Protein and Ubiquitin C-Terminal Hydrolase-L1 Using a Rapid Point of Care Test for Predicting Head Computed Tomography Lesions After Mild Traumatic Brain Injury in a Dutch Multi-Center Cohort","volume":"41","author":"Chayoua","year":"2024","journal-title":"J Neurotrauma"},{"key":"2026061803502147000_16.6.e120021.21","first-page":"313","article-title":"UCH-L1 and GFAP Testing (i-STAT TBI Plasma) for the Detection of Intracranial Injury Following Mild Traumatic Brain Injury","volume":"105","author":"Middleton","year":"2022","journal-title":"Am Fam Physician"},{"key":"2026061803502147000_16.6.e120021.22","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ajem.2024.12.005","article-title":"A high-performance core laboratory GFAP\/UCH-L1 test for the prediction of intracranial injury after mild traumatic brain injury","volume":"89","author":"Welch","year":"2025","journal-title":"Am J Emerg Med"},{"key":"2026061803502147000_16.6.e120021.23","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-071467","article-title":"Study protocol for investigating the clinical performance of an automated blood test for glial fibrillary acidic protein and ubiquitin carboxy-terminal hydrolase L1 blood concentrations in elderly patients with mild traumatic BRAIN Injury and reference values (BRAINI-2 Elderly European study): a prospective multicentre observational study","volume":"13","author":"Lagares","year":"2023","journal-title":"BMJ Open"},{"key":"2026061803502147000_16.6.e120021.24","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S1474-4422(24)00454-X","article-title":"Unique considerations in the assessment and management of traumatic brain injury in older adults","volume":"24","author":"Depreitere","year":"2025","journal-title":"Lancet Neurol"},{"key":"2026061803502147000_16.6.e120021.25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003761","article-title":"The burden of traumatic brain injury from low-energy falls among patients from 18 countries in the CENTER-TBI Registry: A comparative cohort study","volume":"18","author":"Lecky","year":"2021","journal-title":"PLoS Med"},{"key":"2026061803502147000_16.6.e120021.26","doi-asserted-by":"crossref","DOI":"10.1016\/j.bas.2025.104319","article-title":"Consensus on the management of traumatic brain injury in older adults: Results from a Delphi study","volume":"5","author":"Lagares","year":"2025","journal-title":"Brain Spine"},{"key":"2026061803502147000_16.6.e120021.27","doi-asserted-by":"publisher","DOI":"10.1089\/neu.2018.5694"},{"key":"2026061803502147000_16.6.e120021.28","doi-asserted-by":"crossref","DOI":"10.1186\/1757-7241-21-52","article-title":"S100B levels are affected by older age but not by alcohol intoxication following mild traumatic brain injury","volume":"21","author":"Calcagnile","year":"2013","journal-title":"Scand J Trauma Resusc Emerg Med"},{"key":"2026061803502147000_16.6.e120021.29","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/jalm.2019.031393","article-title":"Predictive Performance of Traumatic Brain Injury Biomarkers in High-Risk Elderly Patients","volume":"5","author":"Ward","year":"2020","journal-title":"J Appl Lab Med"},{"key":"2026061803502147000_16.6.e120021.30","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1089\/neu.2022.0270","article-title":"Cost-Effectiveness of Blood-Based Brain Biomarkers for Screening Adults with Mild Traumatic Brain Injury in the French Health Care Setting","volume":"40","author":"Zimmer","year":"2023","journal-title":"J Neurotrauma"},{"key":"2026061803502147000_16.6.e120021.31","doi-asserted-by":"crossref","DOI":"10.1186\/s12883-016-0723-z","article-title":"The addition of S100B to guidelines for management of mild head injury is potentially cost saving","volume":"16","author":"Calcagnile","year":"2016","journal-title":"BMC Neurol"},{"key":"2026061803502147000_16.6.e120021.32","doi-asserted-by":"crossref","DOI":"10.3390\/jcm14124095","article-title":"Budget Impact Analysis of the Use of Specific Biomarkers GFAP and UCH-L1 in the Management of Mild Traumatic Brain Injury in Spain","volume":"14","author":"Moya Torrecilla","year":"2025","journal-title":"J Clin Med"},{"key":"2026061803502147000_16.6.e120021.33","unstructured":"SERAM . Manejo del paciente con traumatismo craneoecef\u00e1lico leve y recomendaciones. 2024. Available: https:\/\/seram.es\/wp-content\/uploads\/2024\/01\/Manejo-del-paciente-con-TCE-leve-y-recomendaciones_VF2.0-002.pdf"},{"key":"2026061803502147000_16.6.e120021.34","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(18)30415-0"},{"key":"2026061803502147000_16.6.e120021.35","doi-asserted-by":"publisher","DOI":"10.5811\/westjem.2018.5.37293"},{"key":"2026061803502147000_16.6.e120021.36","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1080\/14737159.2024.2306876","article-title":"The game changer: UCH-L1 and GFAP-based blood test as the first marketed in vitro diagnostic test for mild traumatic brain injury","volume":"24","author":"Kobeissy","year":"2024","journal-title":"Expert Rev Mol Diagn"},{"key":"2026061803502147000_16.6.e120021.37","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1111\/acem.14366","article-title":"Accuracy of a rapid glial fibrillary acidic protein\/ubiquitin carboxyl-terminal hydrolase L1 test for the prediction of intracranial injuries on head computed tomography after mild traumatic brain injury","volume":"28","author":"Bazarian","year":"2021","journal-title":"Acad Emerg Med"},{"key":"2026061803502147000_16.6.e120021.38","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102785","article-title":"Blood biomarkers on admission in acute traumatic brain injury: Relations to severity, CT findings and care path in the CENTER-TBI study","volume":"56","author":"Czeiter","year":"2020","journal-title":"EBioMedicine"},{"key":"2026061803502147000_16.6.e120021.39","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-043635","article-title":"Study protocol for investigating the performance of an automated blood test measuring GFAP and UCH-L1 in a prospective observational cohort of patients with mild traumatic brain injury: European BRAINI study","volume":"11","author":"Richard","year":"2021","journal-title":"BMJ Open"},{"key":"2026061803502147000_16.6.e120021.40","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1111\/acem.12795","article-title":"Performance of Glial Fibrillary Acidic Protein in Detecting Traumatic Intracranial Lesions on Computed Tomography in Children and Youth With Mild Head Trauma","volume":"22","author":"Papa","year":"2015","journal-title":"Acad Emerg Med"},{"key":"2026061803502147000_16.6.e120021.41","doi-asserted-by":"publisher","DOI":"10.1089\/neu.2013.3040"},{"key":"2026061803502147000_16.6.e120021.42","doi-asserted-by":"publisher","DOI":"10.1016\/s1474-4422(22)00256-3"},{"key":"2026061803502147000_16.6.e120021.43","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(19)30282-0"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2026-120021","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T10:50:48Z","timestamp":1781779848000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2026-120021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":43,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6,18]]},"published-print":{"date-parts":[[2026,6]]}},"alternative-id":["10.1136\/bmjopen-2026-120021"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2026-120021","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6]]}}}